Upon receiving a diabetes diagnosis, patients go through many thoughts, one of the first being medication therapy. Besides medication therapy, the critical component for a healthy life with diabetes is maintaining a healthy lifestyle.
Sodium-glucose transport protein 2 (SGLT-2) inhibitors are a staple in treating patients with type 2 diabetes. Will this standard type 2 diabetes treatment change the treatment choice for patients with gout?
